From the Cover: Does the Assessment of Nondisjunction Provide a More Sensitive Assay for the Detection of Aneugens?

Elloway, Joanne M; Davies, Alexandra K; Hayes, Julie E; Doherty, Ann T

Elloway, Joanne M; Davies, Alexandra K; Hayes, Julie E; Doherty, Ann T.

Affiliation

Elloway JM; AstraZeneca, Innovative Medicines and Early Development, Drug Safety and Metabolism (Discovery Safety), Unit 310-Darwin Building, Cambridge, UK.
Davies AK; AstraZeneca, Innovative Medicines and Early Development, Drug Safety and Metabolism (Discovery Safety), Unit 310-Darwin Building, Cambridge, UK.
Hayes JE; AstraZeneca, Innovative Medicines and Early Development, Drug Safety and Metabolism (Discovery Safety), AstraZeneca R&D, Alderley Park, Macclesfield, Cheshire, UK.
Doherty AT; AstraZeneca, Innovative Medicines and Early Development, Drug Safety and Metabolism (Discovery Safety), Unit 310-Darwin Building, Cambridge, UK.

Toxicol Sci ; 157(1): 20-29, 2017 05 01.

Article in En | MEDLINE | ID: mdl-28087838

Subject(s)
Key words

aneugen; nondisjunction; micronuclei

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nondisjunction, Genetic / Aneugens / Aneuploidy Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Toxicol Sci Journal subject: TOXICOLOGIA Year: 2017 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google